James River
-
The Insurance Insider US news team runs you through the earnings results for the day.
-
CEO Joseph Brown said only that GBLI has had ‘conversations’ with James River.
-
The parties completed the acquisition of JRG Re “at the previously agreed upon terms".
-
Fleming had attempted to land ~$78mn in ‘economic concessions’ on the deal.
-
Altamont-backed Fleming says it remains willing to acquire JRG Reinsurance.
-
A cleaned-up combined entity could make for an attractive investment in a few years.
-
Cove Street is 14th largest investor in Global Indemnity.
-
Sources said that the E&S carriers are now poised to enter due diligence.
-
Shares had fallen over 20% since Monday.
-
The all-stock indicative proposal values the business at more than 2x the share price.
-
James River sued Fleming yesterday to enforce the $277mn sale of its casualty re unit.
-
James River is suing Flemming Intermediate while a potential sale of the company is ongoing.
-
Fleming has claimed breach of contract and is seeking roughly $78mn in “economic concessions”.
-
Parties will be invited to submit bids again later this month.
-
The company’s board continues evaluating strategic options, including a full sale.
-
The carrier’s sales process is ongoing, and it will provide an update “in due course”.
-
Enstar acquired 637,640 shares of James River in Q4 last year valued at nearly $6mn.
-
Given a number of complexities, the landing zone on a take-out price is small.
-
Earlier in the process, sources linked Sentry Insurance with a bid for the E&S insurer.
-
Sources said that the Citi and Ardea-run sale process is being angled to potential strategic buyers in its initial stages.
-
The actions follow James River’s recent announcement that it has identified a material weakness in its internal control over financial reporting and will sell JRG Re.
-
The suspension of Global Indemnity’s effort to sell its E&S arm is likely specific to the franchise rather than an indicator of a dealmaking slowdown.
-
The executive joined the firm in 2019 as senior vice president of program management and has since led the program and fronting business within the specialty admitted insurance segment.
-
James River’s potential sale could be an opportunity for an investor looking to tap the E&S market, but reserving noise means making a deal might not be easy.